18 May 2013
Keywords: targacept, gets, 6m, gsk, milestone, ph, clinical-stage
Article | 17 December 2007
Targacept, a US clinical-stage drug company, has initiated a Phase I clinical trial of its product candidate TC-6499, triggering a $6.0
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 December 2007
17 May 2013
© 2013 thepharmaletter.com